During the EUROPEAN CONGRESS of INTERNAL MEDICINE (ECIM) in Istanbul the Foundation for the Development of Internal Medicine in Europe (FDIME) was involved in a variety of activities.
Improvement in activities of daily living and health status associated with the use of once-weekly semaglutide in very old patients with type 2 diabetes, obesity and heart failure.
Clinical presentation, course and prognosis of patients with mixed connective tissue disease. A multicenter retrospective cohort.
Pathologies and biomarkers for early detection of intestinal ischemia.
IL-1beta/DNA complex ELISA as a simple diagnostic tool for IL-1-mediated auto-inflammatory disease.
For the first time two third prizes were reached out because of equal ranking.